Summary: Evaluated 6 months versus 24 months of dual antiplatelet therapy in patients undergoing coronary stenting. The primary composite endpoint of all-cause mortality, MI or stent thrombosis was not different (24 months of dual antiplatelet therapy non-superior) regardless of stent type (drug eluting or bare metal).

Original Publication:

Circulation. 2012 Apr 24;125(16):2015-26.

Eponym: PROlonging Dual AntIplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia StudY